With safety not being an issue, what I struggle to understand is why they would NOT approve it, when no other treatment options exist.
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-502
-
- There are more pages in this discussion • 353 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.04 |
Change
-0.035(3.27%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.05 | $1.03 | $1.141M | 1.099M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 95527 | $1.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 63135 | 5 |
View Market Depth
| Last trade - 10.13am 30/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |